Ani Pharmaceuticals (ANIP) Gross Margin (2012 - 2026)
Ani Pharmaceuticals' Gross Margin came in at 62.35% for Q2 2026, down 2.35 percentage points from 64.70% a year earlier but up 1.76 percentage points from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Gross Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Ani Pharmaceuticals reported Gross Margin of 60.40%, down 0.66 percentage points year-over-year; for FY2025, it came in at 61.36%, up 2.09 percentage points from FY2024.
- Gross Margin carries a five-year change of +3.17 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 59.27% in FY2024 (-3.44 pp), 62.71% in FY2023 (+6.58 pp), 56.13% in FY2022 (+2.68 pp) and 53.45% in FY2021 (-4.74 pp).
- The five-year range for quarterly Gross Margin is 44.36% (Q4 2021) to 64.70% (Q2 2025).
- Year-over-year, Gross Margin increased in three of the last eight quarters, with an average year-over-year change of -0.50 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q1 2023 (a gain of 17.84 percentage points), and the weakest in Q1 2022 (a drop of 16.50 percentage points).
- Business Quant data shows ANIP's Gross Margin at 60.59% (Q1 2026), 59.42% (Q4 2025) and 59.01% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Ani Pharmaceuticals | 1.78 Bn | 565.34 Mn | 165.89 Mn | 62.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.35% |
| Mar 31, 2026 | 60.59% |
| Dec 31, 2025 | 59.42% |
| Sep 30, 2025 | 59.01% |
| Jun 30, 2025 | 64.70% |
| Mar 31, 2025 | 62.95% |
| Dec 31, 2024 | 57.87% |
| Sep 30, 2024 | 57.48% |
| Jun 30, 2024 | 58.20% |
| Mar 31, 2024 | 64.23% |
| Dec 31, 2023 | 59.42% |
| Sep 30, 2023 | 63.51% |
| Jun 30, 2023 | 63.72% |
| Mar 31, 2023 | 64.69% |
| Dec 31, 2022 | 61.45% |
| Sep 30, 2022 | 60.76% |
| Jun 30, 2022 | 52.21% |
| Mar 31, 2022 | 46.85% |
| Dec 31, 2021 | 44.36% |
| Sep 30, 2021 | 53.11% |
API Access
Ani Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();